Measuring depression: comparison and integration of three scales in the GENDEP study.
about
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trialQuetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trialsEfficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxineGenome-wide linkage on chromosome 10q26 for a dimensional scale of major depressionPairwise measures of causal direction in the epidemiology of sleep problems and depression.Data-driven subtypes of major depressive disorder: a systematic review.Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained.The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.A history of health-related quality of life outcomes in psychiatryPharmacogenetics of antidepressive treatment.Overview of the genetics of major depressive disorderNo change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: (1)H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex.A genome-wide association study of a sustained pattern of antidepressant responsePhysical activity patterns of people affected by depressive and anxiety disorders as measured by accelerometers: a cross-sectional studyA new measure of fear of falling: psychometric properties of the fear of falling questionnaire revised (FFQ-R).Depression sum-scores don't add up: why analyzing specific depression symptoms is essentialSchizotypal Traits are Associated with Poorer Executive Functioning in Healthy Adults.Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Depression Dimensions: Integrating Clinical Signs and Symptoms from the Perspectives of Clinicians and Patients.Measuring depression using item response theory: an examination of three measures of depressive symptomatology.No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression.Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and reviewCandidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.Biomarkers predicting treatment outcome in depression: what is clinically significant?Regional brain metabolic correlates of self-reported depression severity contrasted with clinician ratingsGenome-wide approaches to antidepressant treatment: working towards understanding and predicting response.Self-report and clinician-rated measures of depression severity: can one replace the other?DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEPDepression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptomsComparisons across depression assessment instruments in adolescence and young adulthood: an item response theory study using two linking methodsStandardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales.Evidence for multiple genetic factors underlying DSM-IV criteria for major depression.Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette SyndromeValidation and clinical application of a biopsychosocial model of pain intensity and functional disability in patients with a pediatric chronic pain condition referred to a subspecialty clinicPharmacogenetic considerations in the treatment of psychiatric disorders.Suicidal ideation during antidepressant treatment: do genetic predictors exist?Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV.DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.Assessing anhedonia in depression: Potentials and pitfalls.Subjective Cognitive Impairment and Affective Symptoms: A Systematic Review.
P2860
Q21245266-CE7426A0-C4CA-494F-8EE6-F82DFC9C469CQ21260321-5D9456ED-0CED-4335-BD69-0F31C1D76720Q26864531-948F1595-D889-4E01-BDE7-0AAB462CE264Q28384381-AC17032E-AA85-42D2-9B1B-74855BF40FA1Q30528842-F0DC8780-656C-472D-B61C-DC67C1FD2BA2Q30580130-35D5111E-169C-4EC2-80AC-C42678C87D03Q30597546-74AB7A6E-38FC-417B-AA71-52355E0FA47FQ33929926-DCF021FB-CE5F-4793-888F-595AFA8E6916Q34074643-ACC59036-C52D-47F5-B9EE-8298033E815EQ34090827-E88B180A-37C5-4C59-B8D5-253743F938E5Q34138509-7B4AE1EE-AADB-43F8-92DF-36DC1681031FQ34265564-058BD066-F127-4A18-8222-77FE3787AB44Q34347951-757117FF-5E35-4AB0-A0CE-AE1E0280149CQ34942231-C5ABEBE6-FC86-4357-BC72-1D6DD289699FQ35033791-FA62B9E2-A355-40CA-AFF7-BB7289A3BE05Q35276531-D4277E12-50A1-4D9F-9F62-9D8B586AD802Q35669785-980F66FE-AAF3-40BA-8E20-E96AAFBB2A56Q35755912-44A5726B-2EAB-47EB-BA69-BB5BE12A20E3Q35757412-0AA7FE4F-C5AC-4A82-9158-3437B7DB34ABQ35828016-98F14DCE-D3F9-4FCC-9840-220097160D5EQ36169929-AFA4CC66-F88E-4F77-8BC9-A7DDC5CED262Q36218444-3F8569A0-51C1-43EE-A5B9-8A4E5FB0C6E0Q36539999-9E76C34D-F008-4EAB-A65A-A0D0A6890E76Q36593269-DB8647CB-5034-4F44-9F66-EFCBBF16CD0DQ36632380-0592D49D-59B7-4133-B418-0CDD377EA3A6Q36973699-E516E2D5-35C0-45FA-8C16-EADC71BE1E72Q37113934-14FE2D81-1602-4E0F-8FAD-146232FA6905Q37201357-E9A80FF5-5047-42F0-B292-B50267E1D8AFQ37208565-92D1770A-67E2-4BAF-BF18-7CF373D793DCQ37227515-690DDBB3-CEC2-4DC6-B379-B3A61339D8CDQ37229333-81D59A02-A279-48E2-B7D4-05DEE2400954Q37238584-CD91DC33-9183-46E1-9615-587BAC3CE53EQ37246827-CDC3247A-D4BA-473A-BD38-459A8ECDFE6EQ37286335-E7C18107-B02A-4970-B804-1E0B89CE1218Q37681573-0ED43D01-90D1-457C-806E-8D0BA077CABFQ37885976-25E1727E-F4BE-4DF3-B788-41DB4266567AQ38165888-5CA39F4D-185C-4596-A9D6-96F6CC6DEBD3Q38239554-DEF455B3-60FB-4C5B-8C9F-6D8B55A773D4Q38766919-FFB6EAF6-EADD-410B-BFD8-871FB284C226Q38876313-16C03476-9AF7-487A-AEAD-AC360C658A27
P2860
Measuring depression: comparison and integration of three scales in the GENDEP study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Measuring depression: comparison and integration of three scales in the GENDEP study.
@ast
Measuring depression: comparison and integration of three scales in the GENDEP study.
@en
Measuring depression: comparison and integration of three scales in the GENDEP study.
@nl
type
label
Measuring depression: comparison and integration of three scales in the GENDEP study.
@ast
Measuring depression: comparison and integration of three scales in the GENDEP study.
@en
Measuring depression: comparison and integration of three scales in the GENDEP study.
@nl
prefLabel
Measuring depression: comparison and integration of three scales in the GENDEP study.
@ast
Measuring depression: comparison and integration of three scales in the GENDEP study.
@en
Measuring depression: comparison and integration of three scales in the GENDEP study.
@nl
P2093
P2860
P50
P1476
Measuring depression: comparison and integration of three scales in the GENDEP study.
@en
P2093
Henigsberg N
Janzing JG
McGuffin P
P2860
P304
P356
10.1017/S0033291707001730
P407
P577
2007-10-09T00:00:00Z